Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The goal of this course is to provide an overview of the requirements and procedures for reporting cases of child abuse in Pennsylvania.
Goals and Outcomes
Goals and Learning Outcomes
Child abuse and neglect is widespread and associated with a variety of psychosocial problems. While federal law broadly defines child abuse, each state is charged with refining and specifying what constitutes child abuse and outlining report and investigation procedures. Pennsylvania Code defines categories of mandatory reporters who are required to report cases of suspected child abuse. The Pennsylvania Department of Human Services uses ChildLine, an organizational unit that receives, refers, and maintains reports of abuse investigations. The guidelines outline the process for assessment and investigation procedures for these reports. DHS staff members assess the level of risk to the child and make recommendations for action to ensure the safety and well-being of the child. Practitioners may be involved with intervention activities. Multicultural skills and sensitivities are often required to work with children and families from diverse backgrounds.

After taking this course, you should be able to:

  • Define the meaning of child abuse according to 23 Pennsylvania Consolidated Statutes Title 23 Chapter 63.
  • Identify the physical, psychological, behavioral, and environmental indicators of child abuse.
  • Identify risk factors related to child maltreatment.
  • Outline the procedures for making a report to ChildLine.
  • Define the meaning of child abuse according to 23 Pa.C.S. Chapter 63
  • Describe the physical, psychological, behavioral and environmental indicators of child abuse
  • Identify risk factors related to child maltreatment
  • Outline the procedures for making a report to ChildLine

Course Termination Date: 07/03/21

Course Originally Released On: 06/01/20
Details
Course Details

Course Originally Released on : 6/1/2020

REL-ACU-0-SW60213

Course Author

Dorothy W. Angelini

RN, MSN

Deborah Flowers

MSN, CPNP-PC

Elizabeth Kellerman

MSN, RN

Teresa Crowe

PhD, LICSW, LCSWC

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.